A peptide is a chain of amino acids joined by peptide bonds. The word covers everything from two amino acids up to roughly fifty; beyond that, chemists and biologists usually say protein. The distinction is one of size and folding rather than chemistry, but it matters in practice: short chains are simpler to synthesise, easier to characterise, and tend to act as messengers rather than as structural material or enzymes.
Amino acids, sequences and bonds
Twenty standard amino acids make up the peptides found in biology, and a peptide is defined by the order in which they appear, written from the N-terminus (the free amine end) to the C-terminus (the free carboxyl end). Each peptide bond forms between the carboxyl group of one amino acid and the amine group of the next, releasing a molecule of water. Sequence alone determines what a peptide can do: swapping a single residue can change how it folds, how long it survives in solution, and which receptor it binds.
Many research peptides carry small modifications to the natural sequence. An acetyl group on the N-terminus or an amide on the C-terminus protects the ends from enzymes; a substituted amino acid can slow breakdown or strengthen binding; a fatty-acid chain can let a peptide ride on serum albumin so it stays in circulation longer. These changes are why two peptides with similar names, such as CJC-1295 with and without DAC, behave differently in the literature.
Why peptides are studied so widely
Peptides sit between small-molecule drugs and large biologics. They are large enough to bind receptors with high specificity, yet small enough to be made synthetically with defined purity. Fosgerau and Hoffmann's review of peptide therapeutics counted more than sixty approved peptide medicines and several hundred in clinical development, spanning metabolic, oncology, endocrine and infectious-disease research. The same properties that make peptides attractive as medicines make them useful as laboratory tools for probing receptors and signalling pathways.
- Specificity: a sequence evolved or designed for one receptor tends to leave others alone, which makes experimental results easier to interpret.
- Tunability: single-residue changes let researchers compare analogues and isolate which part of a sequence drives an effect.
- Defined manufacture: solid-phase synthesis produces a known sequence at a measurable purity, so a certificate of analysis can describe exactly what is in the vial.
How research peptides are made
Almost all research peptides are produced by solid-phase peptide synthesis (SPPS), the method Bruce Merrifield introduced in 1963. The growing chain is anchored to a resin bead and amino acids are added one at a time, each step followed by washing away excess reagent. Once the sequence is complete the peptide is cleaved from the resin, purified by high-performance liquid chromatography (HPLC) and confirmed by mass spectrometry. The purity figure on a certificate of analysis comes from that HPLC run: it is the share of the sample's chromatographic signal that belongs to the intended sequence.
The finished material is usually freeze-dried (lyophilised) into a powder, because peptides in solution slowly hydrolyse and oxidise. A lyophilised vial stored cold and dry keeps for a long time; once reconstituted, the clock starts.
Handling peptides in the laboratory
Because peptides are sensitive to heat, moisture, light and mechanical stress, good handling is mostly about avoiding those. Vials are kept refrigerated or frozen until use and allowed to reach room temperature before opening, so condensation does not form on the powder. Reconstitution uses bacteriostatic or sterile water run gently down the inside of the vial rather than sprayed onto the powder, followed by swirling rather than shaking. Our reconstitution guide walks through each step, and the calculator on this site converts vial contents and diluent volume into concentration.
What this means for interpreting research
When reading a study, three details tell you most about whether its results transfer to your own work: the exact sequence and any modifications, the model used (cell culture, animal, or human), and the route and schedule of administration. A finding in cultured cells describes what a peptide can do to a receptor; a finding in an animal model adds absorption, distribution and breakdown; a human trial adds the variability of real physiology. The compound profiles in this hub keep those three things separate so the evidence is easy to weigh.
Key takeaways
- A peptide is a short amino-acid chain, typically under fifty residues, that usually acts as a signalling molecule.
- Sequence and small chemical modifications decide how a peptide behaves; near-identical names can mean different molecules.
- Research peptides are made by solid-phase synthesis and characterised by HPLC and mass spectrometry; the certificate of analysis reports those results.
- Cold, dry, gentle handling preserves peptide integrity; reconstituted solutions are the least stable form.
